ASCO22: Breast cancer research by Sara Tolaney, MD
Breast Cancer phase 3 study results TROPiCS-02 at #ASCO22: Dana-Farber's Sara Tolaney, MD, senior author, says research shows new antibody-drug conjugate produced improved progression-free survival rates compared to chemotherapy in HR+/HER2-neg advanced breast cancer.
Dr. Tolaney received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships ...
